Provided by Tiger Trade Technology Pte. Ltd.

Fennec Pharmaceuticals Inc.

10.62
-0.1600-1.48%
Post-market: 10.620.00000.00%16:15 EDT
Volume:126.30K
Turnover:1.35M
Market Cap:372.41M
PE:-88.50
High:10.88
Open:10.78
Low:10.59
Close:10.78
52wk High:13.25
52wk Low:5.65
Shares:35.07M
Float Shares:19.89M
Volume Ratio:0.64
T/O Rate:0.64%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.1200
EPS(LYR):-0.3409
ROE:-18.58%
ROA:-1.16%
PB:8.77
PE(LYR):-31.16

Loading ...

Fennec presents results from STS-J01 clinical trial evaluating Pedmark

TIPRANKS
·
Sep 17

Fennec Says Phase 2 Japan Study Shows Pedmark Cuts Cisplatin-Linked Hearing Loss to 24% in Pediatric, AYA Patients

Reuters
·
Sep 17

Fennec Pharmaceuticals Announces Oral Presentation of Detailed Results from Investigator-Initiated Phase 2 Sts-J01 Clinical Study of Pedmark® in Japan at Siop 2026

THOMSON REUTERS
·
Sep 17

Fennec Pharmaceuticals Announces Oral Presentation of Detailed Results from Investigator-Initiated Phase 2 STS-J01 Clinical Study of Pedmark® in Japan at SIOP 2026

GlobeNewswire
·
Sep 17

Fennec Pharma Director Marco Maria Brughera Disposes of 15,545 Common Shares Worth $159,958.05

Reuters
·
Sep 17

Fennec Pharmaceuticals Price Target Maintained with a $16.00/Share by HC Wainwright & Co.

Dow Jones
·
Sep 09

Fennec Pharma Former Director Rosty Raykov Disposes of 10,000 Common Shares for $121,100

Reuters
·
Sep 02

Fennec Pharmaceuticals CFO Robert Andrade Sells 75,000 Common Shares for $883,500

Reuters
·
Aug 29

Fennec Pharmaceuticals Publishes Corporate Presentation Highlighting Pedmark Expansion for Cisplatin-Induced Hearing Loss Prevention

Reuters
·
Aug 18

Fennec Pharmaceuticals (FENC) Gets a Buy from Maxim Group

TIPRANKS
·
Aug 13

Fennec Pharmaceuticals is Maintained at Outperform by Wedbush

Dow Jones
·
Aug 13

Fennec Pharmaceuticals (FENC) Gets a Buy from Wedbush

TIPRANKS
·
Aug 12

B. Riley Adjusts Fennec Pharmaceuticals Price Target to $18 From $16, Maintains Buy Rating

MT Newswires Live
·
Aug 12

Canada's Cipher Pharma Q2 Revenue Falls on Lower Natroba Sales Amid Reduced Medicaid Coverage

Reuters
·
Aug 12

Aquestive Therapeutics Q2 Revenue Beats on Suboxone Strength

Reuters
·
Aug 12

Wedbush Adjusts Fennec Pharmaceuticals PT to $16 From $13, Maintains Outperform Rating

MT Newswires Live
·
Aug 11

Fennec Pharmaceuticals Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 11

Fennec Pharmaceuticals Q2 Sales Rise on Pedmark Demand

Reuters
·
Aug 11

Fennec Pharmaceuticals Q2 EPS $0.05 Beats $0.02 Estimate, Sales $17.874M Beat $16.095M Estimate

Benzinga Earnings
·
Aug 11

Fennec Pharmaceuticals Q2 Product Sales USD 17.164 Million

THOMSON REUTERS
·
Aug 11